From: Mild COVID-19 has no detrimental effect on semen quality
COVID-19 (n = 25) | Control group (n = 12) | p-value | |
---|---|---|---|
Age (years) | 34.9 (26.7–43.1) | 26.7 (24.0–34.8) | 0.039a |
Body mass index (kg/m2) | 24.1 (23.1–26.9) | 23.9 (22.3–26.1) | 0.977a |
Smokers | 4 (16.0%) | 5 (41.7%) | 0.088c |
Diabetes mellitus type 2 | 0 | 0 | |
Hypertension in need of medical treatment | 1 | 0 | |
Paternity | 6 (24.0%) | 2 (16.7%) | 0.612c |
Result of fertility treatment | 1 (4.0%) | 1 (8.3%) | > 0.999d |
Testicular cancer | 1 (4.0%) | 1 (8.3%) | > 0.999d |
Semen volume (ml) | 2.8 (2.0–3.9) | 3.9 (2.2–5.0) | 0.131b |
Sperm concentration (106/ml) | 44.0 (23.0–82.0) | 93.5 (23.5–100.0) | 0.140b |
Total sperm number (106/ejaculate) | 136.8 (54.0–228.1) | 204.9 (83.1–550.0) | 0.153b |
Progressive motility (%) | 25.0 (13.5–35.0) | 20.0 (10.0–41.3) | 0.708b |
Total motility (%) | 40.0 (18.5–40.0) | 25.0 (15.0–47.5) | 0.658b |
Normozoospermia (n) | 10 (40%) | 5 (41.7%) | 0.923c |
Time of abstinence (days) | 4 (3.0–6.5) | 3.5 (2.3–4.0) | 0.204b |
SARS CoV-2-positive PCR of ejaculates (n) | 0 | 0 | |
SARS-CoV-2-positive cell cultures of ejaculates (n) | 0 | 0 |